Veri Medtech Holdings Inc. (VRHID)
OTCMKTS · Delayed Price · Currency is USD
5.00
0.00 (0.00%)
Sep 17, 2026, 3:13 PM EDT
Veri Medtech Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 |
| 9.21 | 10.85 | 16.65 | 22.16 | 0.06 | 0.06 | |
Revenue Growth | -31.21% | -34.86% | -24.84% | 34117.17% | 8.88% | -6.46% |
Cost of Revenue | 2.28 | 2.68 | 4.26 | 6.07 | 0.01 | 0.02 |
Gross Profit | 6.94 | 8.17 | 12.39 | 16.08 | 0.05 | 0.04 |
Selling, General & Admin | 8.92 | 10.41 | 12.69 | 12.5 | 0.09 | 0.07 |
Other Operating Expenses | - | - | - | - | 0 | - |
Operating Expenses | 8.92 | 10.41 | 12.69 | 12.5 | 0.09 | 0.07 |
Operating Income | -1.99 | -2.25 | -0.3 | 3.58 | -0.04 | -0.03 |
Interest Expense | -0.07 | -0.07 | -0.11 | -0.1 | -0.01 | -0 |
Other Non Operating Income (Expenses) | 0 | -0 | -0 | 0.05 | - | - |
EBT Excluding Unusual Items | -2.05 | -2.32 | -0.41 | 3.53 | -0.05 | -0.04 |
Gain (Loss) on Sale of Assets | 0.02 | - | - | - | -0.3 | - |
Pretax Income | -2.03 | -2.32 | -0.41 | 3.53 | -0.35 | -0.04 |
Net Income | -2.07 | -2.32 | -0.41 | 3.53 | -0.35 | -0.04 |
Net Income to Common | -2.07 | -2.32 | -0.41 | 3.53 | -0.35 | -0.04 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 8 | 8 | 5 | 4 | 1 | 1 |
Shares Outstanding (Diluted) | 8 | 8 | 5 | 4 | 1 | 1 |
Shares Change | 27.35% | 73.64% | 11.24% | 440.21% | 35.18% | 27.82% |
EPS (Basic) | -0.26 | -0.29 | -0.09 | 0.85 | -0.45 | -0.06 |
EPS (Diluted) | -0.26 | -0.29 | -0.09 | 0.85 | -0.45 | -0.06 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 |
Free Cash Flow | 0.24 | 0.32 | 0.05 | 3.35 | -0.34 | 0.01 |
Free Cash Flow Per Share | 0.03 | 0.04 | 0.01 | 0.81 | -0.45 | 0.01 |
Gross Margin | 75.29% | 75.28% | 74.39% | 72.59% | 81.12% | 63.06% |
Operating Margin | -21.55% | -20.71% | -1.81% | 16.18% | -61.49% | -53.89% |
Profit Margin | -22.50% | -21.39% | -2.46% | 15.93% | -536.33% | -60.54% |
Free Cash Flow Margin | 2.56% | 2.92% | 0.32% | 15.14% | -525.76% | 10.93% |
EBITDA | -1.98 | -2.24 | -0.3 | 3.58 | -0.04 | - |
EBITDA Margin | -21.46% | -20.64% | -1.78% | 16.18% | -61.42% | - |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0 | 0 | - |
EBIT | -1.99 | -2.25 | -0.3 | 3.58 | -0.04 | -0.03 |
EBIT Margin | -21.55% | -20.71% | -1.81% | 16.18% | -61.49% | -53.89% |
Advertising Expenses | - | - | - | - | 0.03 | 0.04 |